MedPath

Effect of gait training using Welwalk and Botulinum Toxin A Injection on gait ability in chronic stroke patients

Not Applicable
Recruiting
Conditions
Chronic stroke patients
Registration Number
JPRN-UMIN000048477
Lead Sponsor
Hyogo medical university
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
20
Inclusion Criteria

Not provided

Exclusion Criteria

1.Cannot obey instructions of a healer (scores < 23 on the Mini Mental Status examination, etc) 2.Significant cardiorespiratory/metabolic disease, or orthopedic injury or other neurological 3.Excessive spasticity (defined as modified Ashworth scale 4 at any lower limb joint) 4.Size limitations for the harness/counterweight system or robotic orthosis 5.Receiving anti-spasticity therapy (Botulinum Toxin A, phenol, baclofen pump, etc.) in the lower extremities within 16 weeks of study entry

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath